Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Intangibles (2016 - 2025)

Historic Intangibles for Standard Biotools (LAB) over the last 12 years, with Q1 2025 value amounting to $28.1 million.

  • Standard Biotools' Intangibles rose 1316.04% to $28.1 million in Q1 2025 from the same period last year, while for Mar 2025 it was $28.1 million, marking a year-over-year increase of 1316.04%. This contributed to the annual value of $29.0 million for FY2024, which is 196814.29% up from last year.
  • As of Q1 2025, Standard Biotools' Intangibles stood at $28.1 million, which was up 1316.04% from $29.0 million recorded in Q4 2024.
  • In the past 5 years, Standard Biotools' Intangibles registered a high of $37.0 million during Q1 2021, and its lowest value of $1.4 million during Q4 2023.
  • For the 5-year period, Standard Biotools' Intangibles averaged around $20.7 million, with its median value being $24.1 million (2024).
  • In the last 5 years, Standard Biotools' Intangibles tumbled by 8888.89% in 2023 and then soared by 196814.29% in 2024.
  • Standard Biotools' Intangibles (Quarter) stood at $27.9 million in 2021, then crashed by 54.88% to $12.6 million in 2022, then plummeted by 88.89% to $1.4 million in 2023, then skyrocketed by 1968.14% to $29.0 million in 2024, then dropped by 3.1% to $28.1 million in 2025.
  • Its last three reported values are $28.1 million in Q1 2025, $29.0 million for Q4 2024, and $23.4 million during Q3 2024.